NPPA and pulmonary arterial hypertension: Nevertheless, available data suggest that KP activation might contribute to pulmonary vascular remodeling of PAH via de novo NAD+ synthesis. Hence, future studies should investigate whether inhibition of de novo NAD+ synthesis, via inhibition of KP activity, may provide a novel therapeutic target for PAH.